SEC Form 4 · accession 0001645627-15-000004
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Aug 19, 2015
Accepted (ET)
Aug 26, 2015 · 10:56 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 24, 2015 | P | 100 | $0.07 | A | 19,593,515 | D | |
| Common Stock | Aug 24, 2015 | P | 100 | $0.07 | A | 19,593,615 | D | |
| Common Stock | Aug 24, 2015 | P | 100 | $0.07 | A | 19,593,715 | D | |
| Common Stock | Aug 24, 2015 | P | 100 | $0.07 | A | 19,593,815 | D | |
| Common Stock | Aug 24, 2015 | P | 100 | $0.075 | A | 19,593,915 | D | |
| Common Stock | Aug 25, 2015 | P | 100 | $0.075 | A | 19,594,015 | D | |
| Common Stock | Aug 25, 2015 | P | 100 | $0.075 | A | 19,594,115 | D | |
| Common Stock | Aug 25, 2015 | P | 100 | $0.079 | A | 19,594,215 | D | |
| Common Stock | Aug 25, 2015 | P | 100 | $0.079 | A | 19,594,315 | D | |
| Common Stock | Aug 25, 2015 | P | 100 | $0.08 | A | 19,594,415 | D |
Table II — derivative securities
No Table II lines on this filing.